Meeting of the Board of Scientific Counselors, Office of Readiness and Response, 83689 [2024-23926]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 201 / Thursday, October 17, 2024 / Notices
Shortage Workgroup Update. Agenda
items are subject to change as priorities
dictate.
Public Participation
Written Public Comment: Members of
the public are welcome to submit
written comments in advance of the
meeting. Written comments must be
submitted by emailing nchhstppolicy@
cdc.gov with subject line ‘‘ACET
December 2024 Public Comment
Registration’’ by November 26, 2024.
Oral Public Comment: Individuals
who would like to make an oral
comment during the public comment
period must register by emailing
nchhstppolicy@cdc.gov with subject
line ‘‘ACET December 2024 Public
Comment Registration’’ by November
26, 2024. The public comment period is
on December 4, 2024, at 10:15 a.m.,
EST.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–23885 Filed 10–16–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Meeting of the Board of Scientific
Counselors, Office of Readiness and
Response
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC) announces the
following meeting for the Board of
Scientific Counselors, Office of
Readiness and Response (BSC, ORR).
This is a virtual meeting and is open to
the public, limited only by the number
of web conference lines available (500
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:31 Oct 16, 2024
Jkt 265001
lines). Time will be available for public
comment.
DATES: The meeting will be held on
November 20, 2024, from 9:30 a.m. to
4:30 p.m., EST, and November 21, 2024,
from 9 a.m. to 3 p.m., EST.
ADDRESSES: Zoom virtual meeting. If
you wish to attend the meeting, please
register in advance by accessing the link
at https://cdc.zoomgov.com/webinar/
register/WN_
sIWaL9XVRqWnBKMB2OO2wQ#/
registration. Instructions on accessing
the meeting will be provided following
registration.
FOR FURTHER INFORMATION CONTACT:
Dometa Ouisley, Public Health Analyst,
Office of Science and Laboratory
Readiness, Office of Readiness and
Response, Centers for Disease Control
and Prevention, 1600 Clifton Road NE,
Mailstop H21–6, Atlanta, Georgia
30329–4027. Telephone: (404) 639–
7450; Email: DOuisley@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Board of Scientific
Counselors, Office of Readiness and
Response provides advice and guidance
to the Secretary, Department of Health
and Human Services (HHS); the
Assistant Secretary for Health, HHS; the
Director, Centers for Disease Control
and Prevention (CDC); and the Director,
Office of Readiness and Response
(ORR), CDC. The Board recommends
strategies and goals for readiness and
response activities pertaining to
programs and research within the
agency and the ORR divisions and
monitors the overall strategic direction
and focus of the ORR divisions and
offices. The Board may also perform
second-level peer review of applications
for grants-in-aid for research and
research training activities, cooperative
agreements, and research contract
proposals relating to the broad areas
within the center. For additional
information about the Board, please
visit https://www.cdc.gov/orr/scientificcounselors/.
Matters to be Considered: Agenda
topics for Day 1 of the meeting include
ORR Updates, ORR Division Director
Updates, CDC’s Response Readiness
Framework, and a CDCReady
Demonstration. Agenda topics for Day 2
include Poliovirus Containment
Working Group Updates, ORR Science
Agenda Working Group Updates, and
Health Equity Working Group Updates.
Agenda items are subject to change as
priorities dictate.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
83689
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–23926 Filed 10–16–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3466–PN]
Medicare and Medicaid Programs:
Application From the American
Association for Accreditation of
Ambulatory Surgery Facilities dba
QUAD A for Continued CMS-Approval
of Its Outpatient Physical Therapy
(OPT) Accreditation Program
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice with request for
comment.
AGENCY:
This notice acknowledges the
receipt of an application from the
American Association for Accreditation
of Ambulatory Surgery Facilities, dba
QUAD A, for continued recognition as
a national accrediting organization for
outpatient physical therapy providers
that wish to participate in the Medicare
or Medicaid programs.
DATES: To be assured consideration,
comments must be received at one of
the addresses provided below, no later
than 5 p.m. on November 18, 2024.
ADDRESSES: In commenting, refer to file
code CMS–3466–PN. Because of staff
and resource limitations, we cannot
accept comments by facsimile (FAX)
transmission.
Comments, including mass comment
submissions, must be submitted in one
of the following three ways (please
choose only one of the ways listed):
1. Electronically. You may submit
electronic comments on this regulation
to https://www.regulations.gov. Follow
the ‘‘Submit a comment’’ instructions.
2. By regular mail. You may mail
written comments to the following
address ONLY: Centers for Medicare &
Medicaid Services, Department of
Health and Human Services, Attention:
CMS–3466–PN, P.O. Box 8010,
Baltimore, MD 21244–8010.
SUMMARY:
E:\FR\FM\17OCN1.SGM
17OCN1
]]>Agencies
[Federal Register Volume 89, Number 201 (Thursday, October 17, 2024)]
[Notices]
[Page 83689]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-23926]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Meeting of the Board of Scientific Counselors, Office of
Readiness and Response
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC) announces the
following meeting for the Board of Scientific Counselors, Office of
Readiness and Response (BSC, ORR). This is a virtual meeting and is
open to the public, limited only by the number of web conference lines
available (500 lines). Time will be available for public comment.
DATES: The meeting will be held on November 20, 2024, from 9:30 a.m. to
4:30 p.m., EST, and November 21, 2024, from 9 a.m. to 3 p.m., EST.
ADDRESSES: Zoom virtual meeting. If you wish to attend the meeting,
please register in advance by accessing the link at https://cdc.zoomgov.com/webinar/register/WN_sIWaL9XVRqWnBKMB2OO2wQ#/registration. Instructions on accessing the meeting will be provided
following registration.
FOR FURTHER INFORMATION CONTACT: Dometa Ouisley, Public Health Analyst,
Office of Science and Laboratory Readiness, Office of Readiness and
Response, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, Mailstop H21-6, Atlanta, Georgia 30329-4027. Telephone: (404) 639-
7450; Email: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Board of Scientific Counselors, Office of Readiness
and Response provides advice and guidance to the Secretary, Department
of Health and Human Services (HHS); the Assistant Secretary for Health,
HHS; the Director, Centers for Disease Control and Prevention (CDC);
and the Director, Office of Readiness and Response (ORR), CDC. The
Board recommends strategies and goals for readiness and response
activities pertaining to programs and research within the agency and
the ORR divisions and monitors the overall strategic direction and
focus of the ORR divisions and offices. The Board may also perform
second-level peer review of applications for grants-in-aid for research
and research training activities, cooperative agreements, and research
contract proposals relating to the broad areas within the center. For
additional information about the Board, please visit https://www.cdc.gov/orr/scientific-counselors/.
Matters to be Considered: Agenda topics for Day 1 of the meeting
include ORR Updates, ORR Division Director Updates, CDC's Response
Readiness Framework, and a CDCReady Demonstration. Agenda topics for
Day 2 include Poliovirus Containment Working Group Updates, ORR Science
Agenda Working Group Updates, and Health Equity Working Group Updates.
Agenda items are subject to change as priorities dictate.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-23926 Filed 10-16-24; 8:45 am]
BILLING CODE 4163-18-P
